D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

Benzinga · 06/09 12:12
D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:OSTX) with a Buy and maintains $20 price target.